ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,032, issued on June 17, was assigned to DUKE UNIVERSITY (Durham, N.C.).
"Quinone reductase 2 inhibitor compounds and uses thereof" was invented by Christopher D. Lascola (Durham, N.C.) and Daniel T. Laskowitz (Chapel Hill, N.C.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein according to some embodiments is a compound of Formula (I): [Formula], or a pharmaceutically acceptable salt or prodrug thereof. Compositions comprising the compound, and uses thereof for inhibiting the activity of quinone reductase-2, as well as in methods of treatment, are also provided."
The patent was filed on Oct. 16, 2019, under Application No. 17/285,622....